|
Twitter
|
Facebook
|
Google+
|
VKontakte
|
LinkedIn
|
Viadeo
|
English
|
Français
|
Español
|
العربية
|
 
International Journal of Innovation and Applied Studies
ISSN: 2028-9324     CODEN: IJIABO     OCLC Number: 828807274     ZDB-ID: 2703985-7
 
 
Monday 03 August 2020

About IJIAS

News

Submission

Downloads

Archives

Custom Search

Contact

Connect with IJIAS

  Now IJIAS is indexed in EBSCO, ResearchGate, ProQuest, Chemical Abstracts Service, Index Copernicus, IET Inspec Direct, Ulrichs Web, Google Scholar, CAS Abstracts, J-Gate, UDL Library, CiteSeerX, WorldCat, Scirus, Research Bible and getCited, etc.  
 
 
 

Carcinosarcoma of the ovary: A case report


[ Le carcinosarcome ovarien: A propos d’un cas ]

Volume 30, Issue 1, July 2020, Pages 288–294

 Carcinosarcoma of the ovary: A case report

J. Meddah1, C. Mohammadine2, F. Tijami3, and H. Hachi4

1 Service de gynécologie obstétrique cancérologie et grossesse à haut risque, Maternité Souissi, Université Mohamed V, Rabat, Morocco
2 Service de Gynécologie-Obstétrique, de Cancérologie et de Grossesses à Haut Risque, CHU Ibn Sina, Rabat, Morocco
3 Pole gynéco-mammaire, Institut national d’oncologie Université Mohammed V Souissi, Rabat, Morocco
4 Pole gynéco-mammaire, Institut national d’oncologie Université Mohammed V Souissi, Rabat, Morocco

Original language: French

Received 10 June 2020

Copyright © 2020 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract


Ovarian carcinosarcoma is a rare malignant gynecological tumor that accounts for about 1% of all ovarian cancers. The positive diagnosis of this disease is based on clinical examination, radiological examinations and essentially histological confirmation: the association of a carcinomatous component with a sarcomatous component. Generally, the treatment performed is surgical cytoreduction, followed by chemotherapy and/or radiotherapy. As the prognosis is poor, the survival rate will depend mainly on the quality of surgical management.Multicenter or multinational studies, based on genetic and molecular signaling pathways, are required to better understand this tumor subtype and compare its treatment modalities.

Author Keywords: Ovarian carcinosarcoma, rare cancer, poor prognosis, surgical reduction, chemotherapy.


Abstract: (french)


Le carcinosarcome ovarien est une tumeur gynécologique maligne rare qui représente environ 1% de l’ensemble des cancers ovariens. Le diagnostic positif de cette maladie repose sur l’examen clinique, les examens radiologiques et essentiellement la confirmation histologique : l’association d’une composante carcinomateuse à une composante sarcomateuse. Généralement, le traitement réalisé est la cytoréduction chirurgicale, suivie d’une chimiothérapie et/ou d’une radiothérapie. Le pronostic étant sombre, le taux de survie dépendra essentiellement de la qualité de la prise en charge chirurgicale.Des études multicentriques ou multinationales, basés sur les voies de signalisation génétique et moléculaire, sont requises afin de mieux comprendre ce sous-type de tumeur et de comparer ses modalités de traitement.

Author Keywords: Carcinosarcome ovarien, cancer rare, pronostic sombre, réduction chirurgicale, chimiothérapie.


How to Cite this Article


J. Meddah, C. Mohammadine, F. Tijami, and H. Hachi, “Carcinosarcoma of the ovary: A case report,” International Journal of Innovation and Applied Studies, vol. 30, no. 1, pp. 288–294, July 2020.